NYSE - Nasdaq Real Time Price ? USD IQVIA Holdings Inc. (IQV) Follow Compare 192.68 -10.26 (-5.06%) At close: November 15 at 4:00 PM EST 198.01 +5.33 (+2.77%) After hours: November 15 at 7:51 PM EST All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations IQVIA CFO Ron Bruehlman to Speak at the UBS Global Healthcare Conference on November 13, 2024 RESEARCH TRIANGLE PARK, N.C., November 06, 2024--IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV) announced today that Ron Bruehlman, executive vice president and chief financial officer, will speak at the UBS Healthcare Conference in Rancho Palos Verdes, California on Wednesday, November 13, 2024 at 1:15 p.m. ET. Business Wire ? 11 days ago IQV -5.06% Iqvia price target lowered to $265 from $280 at Morgan Stanley Morgan Stanley lowered the firm’s price target on Iqvia (IQV) to $265 from $280 and keeps an Overweight rating on the shares. A “modest beat” in Q3 was led by better-than-expected TAS performance, but this is overshadowed by R&DS headwinds over the next twelve months, including a single large cancellation and two “mega trial delays” to 2025, the analyst tells investors in a post-earnings note. The firm views the risk/reward as attractive on the recent pullback, the analyst added. Published first TipRanks ? 12 days ago IQV -5.06% Interpreting IQVIA (IQV) International Revenue Trends Evaluate IQVIA's (IQV) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance. Zacks ? 13 days ago IQV -5.06% IQVIA Holdings Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags IQVIA Holdings ( NYSE:IQV ) Third Quarter 2024 Results Key Financial Results Revenue: US$3.90b (up 4.3% from 3Q 2023... Simply Wall St. ? 16 days ago IQV -5.06% IQVIA Holdings Inc (IQV) Q3 2024 Earnings Call Highlights: Strong EPS Growth Amid Market Challenges IQVIA Holdings Inc (IQV) reports robust financial performance with a 14% increase in adjusted diluted EPS, despite facing competitive pricing pressures and trial delays. GuruFocus.com ? 16 days ago IQV -5.06% Decoding IQVIA Holdings Inc (IQV): A Strategic SWOT Insight Unveiling the Financial Dynamics and Strategic Directions GuruFocus.com ? 17 days ago IQV -5.06% Q3 2024 IQVIA Holdings Inc Earnings Call Q3 2024 IQVIA Holdings Inc Earnings Call Thomson Reuters StreetEvents ? 17 days ago IQV -5.06% IQVIA (IQV) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates While the top- and bottom-line numbers for IQVIA (IQV) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values. Zacks ? 17 days ago IQV -5.06% IQVIA Earnings & Revenues Surpass Estimates in Q3, Increase Y/Y Strength in the Research and Development, and Technology and Analytics segments drives IQV's top line in the third quarter of 2024. Zacks ? 17 days ago IQV -5.06% Veeva Systems Collaborates With Walgreens to Improve Patient Outcomes VEEV partners with Walgreens to provide better patient outcomes to life sciences companies. Zacks ? 17 days ago VEEV WBA IQV -5.06% IQVIA Holdings (IQV) Q3 Earnings and Revenues Beat Estimates IQVIA (IQV) delivered earnings and revenue surprises of 1.07% and 1.11%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock? Zacks ? 17 days ago IQV -5.06% IQVIA: Q3 Earnings Snapshot The Durham, North Carolina-based company said it had profit of $1.55 per share. Earnings, adjusted for one-time gains and costs, came to $2.84 per share. The results topped Wall Street expectations. Associated Press Finance ? 17 days ago IQV -5.06% IQVIA Reports Third-Quarter 2024 Results and Announces Investor Day RESEARCH TRIANGLE PARK, N.C., October 31, 2024--IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today reported financial results for the quarter ended September 30, 2024. Business Wire ? 17 days ago IQV -5.06% IQVIA Holdings Inc. (IQV): Among UBS’ Top Tech Based Disruptive Stocks For 2030 We recently compiled a list of the UBS’ Top Tech Based Disruptive Stocks For 2030: Top 29 Stocks. In this article, we are going to take a look at where IQVIA Holdings Inc. (NYSE:IQV) stands against the other tech based disruptive stocks. When it comes to investing and making massive gains on the stock market, disruption […] Insider Monkey ? 18 days ago IQV -5.06% IQVIA Gears Up to Report Q3 Earnings: Here's What You Should Know IQV's TAS and RD&S revenues are anticipated to have increased, while CSMS revenues are likely to have dipped in the third quarter of 2024. Zacks ? 20 days ago IQV -5.06% MA Hologic (HOLX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release Hologic (HOLX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. Zacks ? 20 days ago HOLX IQV -5.06% Seeking Clues to IQVIA (IQV) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics Besides Wall Street's top -and-bottom-line estimates for IQVIA (IQV), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2024. Zacks ? 20 days ago IQV -5.06% IQVIA Holdings (IQV) Reports Next Week: Wall Street Expects Earnings Growth IQVIA (IQV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. Zacks ? 24 days ago IQV -5.06% TMDX IQVIA to Announce Third-Quarter 2024 Results on October 31, 2024 RESEARCH TRIANGLE PARK, N.C., October 15, 2024--IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV) will announce its third-quarter 2024 financial results before the market opens on Thursday, October 31, 2024. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that same day. The earnings release and accompanying financial information will be posted on the IQVIA Investor Relations website at https://ir.iqvia.com. Business Wire ? last month IQV -5.06% Here's Why You Should Retain IQVIA Holdings Shares Now While IQV benefits from its market leadership, data-driven innovation and global expansion, it must navigate pricing pressure. Zacks ? last month IQV -5.06% Performance Overview Trailing total returns as of 11/15/2024, which may include dividends or other distributions. Benchmark is S&P 500 Return IQV S&P 500 YTD -16.73% +23.08% 1-Year -3.89% +30.58% 3-Year -24.34% +25.36%
